We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies
CLGN

18 hedge funds and large institutions have $2.53M invested in CollPlant Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

3.5% more ownership

Funds ownership: 11.28% → 14.78% (+3.5%)

24% less capital invested

Capital invested by funds: $3.33M → $2.53M (-$799K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCM
Heights Capital Management
California
+$570K
2
AFM
Anson Funds Management
Texas
+$330K
3
SDJVC
St. Denis J. Villere & Co
Louisiana
+$130K
4
AE
AMH Equity
New York
+$74.3K
5
Renaissance Technologies
Renaissance Technologies
New York
+$64.8K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$62.1K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
3
Osaic Holdings
Osaic Holdings
Arizona
-$135
4
Brown Advisory
Brown Advisory
Maryland
-$39
Name Holding Trade Value Shares
Change 		Change in
Stake
SDJVC
1
St. Denis J. Villere & Co
Louisiana
$744K +$130K +63,000 +13%
PA
2
Pinnacle Associates
New York
$690K +$37.3K +18,000 +4%
HCM
3
Heights Capital Management
California
$377K +$570K +275,082 New
AE
4
AMH Equity
New York
$219K +$74.3K +35,849 +29%
AFM
5
Anson Funds Management
Texas
$217K +$330K +159,401 New
Brown Advisory
6
Brown Advisory
Maryland
$151K -$39 -19 -0%
Renaissance Technologies
7
Renaissance Technologies
New York
$56.6K +$64.8K +31,300 +304%
Pathstone Holdings
8
Pathstone Holdings
New Jersey
$23.1K +$35.2K +17,000 +100%
WPC
9
Waters Parkerson & Co
Louisiana
$18K – – –
Wells Fargo
10
Wells Fargo
California
$16.9K +$2.07K +1,000 +9%
TSS
11
Two Sigma Securities
New York
$14.1K +$21.4K +10,349 New
PA
12
Parallel Advisors
California
$4.42K – – –
Bank of America
13
Bank of America
North Carolina
$3.4K – – –
Osaic Holdings
14
Osaic Holdings
Arizona
$455 -$135 -65 -16%
National Bank of Canada
15
National Bank of Canada
Quebec, Canada
$338 – – –
SS
16
SBI Securities
Japan
$272 – – –
Morgan Stanley
17
Morgan Stanley
New York
$3 – – –
UBS Group
18
UBS Group
Switzerland
– -$62.1K -24,074 Closed
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
– -$1K -500 Closed
Simplex Trading
20
Simplex Trading
Illinois
– +$193 +93 New

CLGN Hedge Fund Activity: Q2 2025 in Review

18 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q2 2025, worth a combined $2.53M — down 24% from $3.33M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CLGN positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Heights Capital Management, opening a new position worth an estimated $570K. The largest seller was UBS Group, exiting entirely with an estimated $62.1K sold.

  • 18 institutional investors held CollPlant Biotechnologies (CLGN) as of Q2 2025, up from 16 in Q1 2025.
  • Funds reported $2.53M of CollPlant Biotechnologies stock for Q2 2025, down 24% quarter-over-quarter.
  • 4 funds opened new CollPlant Biotechnologies positions in Q2 2025 and 2 closed out, a net change of +2 holders.
  • The largest CollPlant Biotechnologies buyer in Q2 2025 was Heights Capital Management, an estimated $570K added.
  • The largest CollPlant Biotechnologies seller in Q2 2025 was UBS Group, an estimated $62.1K sold.

Based on aggregated 13F filings for Q2 2025.